ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 01/21/2022
Closing price: 220.52
Support price level: N/A
Resistance price level: $238.00
Relative strength index (14-day RSI) 36.8
Beta 0.82
  • BIIB is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.

  • With a -18.2 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.

  • Volatility is forecast to fall over the next month.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$220.52 $414.71 0.0%
200 day 50 day 20 day 10 day
$292.20 $240.44 $236.40 $232.18
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
44.6% 37.8% 42.7% 46.8%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 11.6% in the next week.

  • 26.5% in the next month.

  • 107.5% in the next year.